CAPR short interest
Capricor Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 18,825,352 |
|---|---|
| Change vs prior report | -855,296 (-4.3%) |
| Change over six months | +90.6% |
| Days to cover | 4.52 (sector: 3.78) |
| Average daily volume | 4,165,921 |
| Rank in Healthcare | #462 of 922 by days to cover |
CAPR short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 18,825,352 | -4.3% | 4.52 | 4,165,921 |
| 2026-09-15 | 19,680,648 | -11.3% | 5.92 | 3,321,739 |
| 2026-08-31 | 22,183,275 | +24.9% | 1.99 | 11,135,624 |
| 2026-08-14 | 17,754,953 | +11.1% | 1.64 | 10,826,270 |
| 2026-07-31 | 15,984,662 | +2.6% | 2.06 | 7,747,120 |
| 2026-07-15 | 15,578,639 | +5.7% | 10.79 | 1,443,737 |
| 2026-06-30 | 14,739,307 | +26.0% | 7.38 | 1,997,195 |
| 2026-06-15 | 11,700,557 | +5.7% | 13.69 | 854,754 |
| 2026-05-29 | 11,068,139 | +1.4% | 14.28 | 774,846 |
| 2026-05-15 | 10,915,855 | +3.8% | 8.19 | 1,332,358 |
| 2026-04-30 | 10,515,168 | +4.8% | 12.68 | 829,033 |
| 2026-04-15 | 10,036,812 | +1.6% | 9.52 | 1,054,571 |
| 2026-03-31 | 9,878,573 | +34.6% | 6.69 | 1,477,571 |
| 2026-03-13 | 7,340,980 | +6.5% | 4.03 | 1,821,303 |
| 2026-02-27 | 6,890,271 | +3.9% | 5.77 | 1,193,801 |
| 2026-02-13 | 6,630,769 | +13.3% | 7.33 | 904,397 |
| 2026-01-30 | 5,851,683 | +14.6% | 4.88 | 1,200,239 |
| 2026-01-15 | 5,106,355 | +0.8% | 3.39 | 1,505,718 |
| 2025-12-31 | 5,064,287 | +0.7% | 4.60 | 1,101,451 |
| 2025-12-15 | 5,029,282 | -69.4% | 1.00 | 8,567,200 |
| 2025-11-28 | 16,419,579 | +16.0% | 7.18 | 2,288,226 |
| 2025-11-14 | 14,153,661 | +6.8% | 7.90 | 1,790,917 |
| 2025-10-31 | 13,254,083 | +8.2% | 10.85 | 1,221,950 |
| 2025-10-15 | 12,248,657 | +4.3% | 11.27 | 1,086,598 |
| 2025-09-30 | 11,738,250 | -3.4% | 7.18 | 1,634,126 |
import finzdata as yf
yf.Ticker("CAPR").short_interest # every report since 2017
yf.Client().short_interest(["CAPR"], start="2018-01-01")Healthcare short interest · CAPR price history · Who owns CAPR · All short interest